Exact Sciences Corp. EXAS

MADISON, Wis., Nov. 1, 2023 /PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that company management will participate in the following conferences and invited investors to participate by webcast.

• Stifel Healthcare Conference, New York
  Fireside chat on Tuesday, November 14, 2023 at 10:20 a.m. ET
  
  
• Jefferies London Healthcare Conference, London
  Fireside chat on Wednesday, November 15, 2023 at 9:30 a.m. ET
  
  
• Piper Sandler 35^th Annual Healthcare Conference, New York
  Fireside chat on Tuesday, November 28, 2023 at 2:00 p.m. ET
  
  
• Evercore ISI HealthCONx Conference, Miami
  Fireside chat on Wednesday, November 29, 2023 at 12:30 p.m. ET

The webcasts can be accessed in the investor relations section of Exact Sciences' website at www.exactsciences.com.

About Exact Sciences Corp.
A leading provider of cancer screening and diagnostic tests, Exact Sciences gives patients and health care professionals the clarity needed to take life-changing action earlier. Building on the success of the Cologuard® and Oncotype® tests, Exact Sciences is investing in its pipeline to develop innovative solutions for use before, during, and after a cancer diagnosis. For more information, visit ExactSciences.com, follow Exact Sciences on X (formerly known as Twitter) @ExactSciences, or find Exact Sciences on LinkedIn and Facebook.

Contact:
Megan Jones
Exact Sciences Corp.
meganjones@exactsciences.com
608-535-8815

View original content to download multimedia:https://www.prnewswire.com/news-releases/exact-sciences-to-participate-in-november-investor-conferences-301973859.html

SOURCE Exact Sciences Corporation